首页 > 最新文献

ImmunoHorizons最新文献

英文 中文
Anti-Inflammatory Role of TRPV4 in Human Macrophages. TRPV4在人类巨噬细胞中的抗炎作用。
Pub Date : 2023-01-01 DOI: 10.4049/immunohorizons.2200100
Yukiko Atsumi, Manami Toriyama, Hiroko Kato, Motoki Nakamura, Akimichi Morita, Masayuki Takaishi, Kaori Saito, Miku Tanaka, Fumihiro Okada, Makoto Tominaga, Ken J Ishii, Fumitaka Fujita

The pathology of skin immune diseases such as atopic dermatitis is closely related to the overproduction of cytokines by macrophages. Although the pathological functions of macrophages in skin are known, mechanisms of how they detect the tissue environment remain unknown. TRPV4, a nonselective cation channel with high Ca2+ permeability, is activated at physiological temperatures from 27 to 35°C and involved in the functional control of macrophages. However, the relationship between TRPV4 function in macrophages and skin immune disease is unclear. In this study, we demonstrate that TRPV4 activation inhibits NF-κB signaling, resulting in the suppression of IL-1β production in both human primary monocytes and macrophages derived from human primary monocytes. A TRPV4 activator also inhibited the differentiation of human primary monocytes into GM-CSF M1 macrophages but not M-CSF M2 macrophages. We also observed a significant increase in the number of inducible NO synthase-positive/TRPV4-negative dermal macrophages in atopic dermatitis compared with healthy human skin specimens. Our findings provide insight into the physiological relevance of TRPV4 to the regulation of macrophages during homeostasis maintenance and raise the potential for TRPV4 to be an anti-inflammatory target.

特应性皮炎等皮肤免疫性疾病的病理学与巨噬细胞过度产生细胞因子密切相关。尽管巨噬细胞在皮肤中的病理功能是已知的,但它们如何检测组织环境的机制仍然未知。TRPV4是一种具有高Ca2+渗透性的非选择性阳离子通道,在27-35°C的生理温度下被激活,并参与巨噬细胞的功能控制。然而,TRPV4在巨噬细胞中的功能与皮肤免疫疾病之间的关系尚不清楚。在这项研究中,我们证明TRPV4的激活抑制了NF-κB信号传导,从而抑制了人原代单核细胞和来源于人单核细胞的巨噬细胞中IL-1β的产生。TRPV4激活剂还抑制人原代单核细胞分化为GM-CSF M1巨噬细胞,但不抑制M-CSF M2巨噬细胞。我们还观察到,与健康人类皮肤标本相比,特应性皮炎中诱导型NO合酶阳性/TRPV4阴性真皮巨噬细胞的数量显著增加。我们的发现深入了解了TRPV4在体内平衡维持过程中与巨噬细胞调节的生理相关性,并提高了TRPV4-成为抗炎靶点的潜力。
{"title":"Anti-Inflammatory Role of TRPV4 in Human Macrophages.","authors":"Yukiko Atsumi,&nbsp;Manami Toriyama,&nbsp;Hiroko Kato,&nbsp;Motoki Nakamura,&nbsp;Akimichi Morita,&nbsp;Masayuki Takaishi,&nbsp;Kaori Saito,&nbsp;Miku Tanaka,&nbsp;Fumihiro Okada,&nbsp;Makoto Tominaga,&nbsp;Ken J Ishii,&nbsp;Fumitaka Fujita","doi":"10.4049/immunohorizons.2200100","DOIUrl":"10.4049/immunohorizons.2200100","url":null,"abstract":"<p><p>The pathology of skin immune diseases such as atopic dermatitis is closely related to the overproduction of cytokines by macrophages. Although the pathological functions of macrophages in skin are known, mechanisms of how they detect the tissue environment remain unknown. TRPV4, a nonselective cation channel with high Ca2+ permeability, is activated at physiological temperatures from 27 to 35°C and involved in the functional control of macrophages. However, the relationship between TRPV4 function in macrophages and skin immune disease is unclear. In this study, we demonstrate that TRPV4 activation inhibits NF-κB signaling, resulting in the suppression of IL-1β production in both human primary monocytes and macrophages derived from human primary monocytes. A TRPV4 activator also inhibited the differentiation of human primary monocytes into GM-CSF M1 macrophages but not M-CSF M2 macrophages. We also observed a significant increase in the number of inducible NO synthase-positive/TRPV4-negative dermal macrophages in atopic dermatitis compared with healthy human skin specimens. Our findings provide insight into the physiological relevance of TRPV4 to the regulation of macrophages during homeostasis maintenance and raise the potential for TRPV4 to be an anti-inflammatory target.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563396/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10704009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Mucosal-Associated Invariant T Cell Function and Expansion with Human Selective Serum. 人选择性血清增强粘膜相关不变T细胞功能和扩增。
Pub Date : 2023-01-01 DOI: 10.4049/immunohorizons.2200082
Daniel Labuz, Jackson Cacioppo, Kelin Li, Jeffrey Aubé, Daniel T Leung

Mucosal-associated invariant T (MAIT) cells are promising innate-like lymphocytes with potential for use in anti-tumor immunotherapy. Existing MAIT cell expansion protocols are associated with potentially decremental phenotypic changes, including increased frequency of CD4+ MAIT cells and higher inhibitory receptor expression. In this study, we compared the effect on expansion of human MAIT cells of a serum replacement, Physiologix XF SR (Phx), with traditional serum FBS for supplementing RPMI 1640 media. Using flow cytometry, we found that Phx supported a significantly higher proliferative capacity for MAIT cells and resulted in a lower frequency of CD4+ MAIT cells, which have been associated with reduced Th1 effector and cytolytic functions. We saw that culturing MAIT cells in Phx led to better survival of MAIT cells and lower frequency of PD-1+ MAIT cells than FBS-supplemented media. Functionally, we saw that Phx supplementation was associated with a higher frequency of IFN-γ+ MAIT cells after stimulation with Escherichia coli than FBS-supplemented RPMI. In conclusion, we show that MAIT cells cultured in Phx have higher proliferative capacity, lower expression of inhibitory receptors, and higher capacity to produce IFN-γ after E. coli stimulation than FBS-supplemented RPMI. This work shows that expanding MAIT cells with Phx compared with FBS-supplemented RPMI results in a more functionally desirable MAIT cell for future anti-tumor immunotherapy.

mucal -associated invariant T (MAIT)细胞是一种很有前途的先天样淋巴细胞,具有抗肿瘤免疫治疗的潜力。现有的MAIT细胞扩增方案与潜在的减少表型变化相关,包括CD4+ MAIT细胞频率增加和抑制性受体表达增加。在这项研究中,我们比较了血清替代品physiologx XF SR (Phx)与传统血清FBS补充RPMI 1640培养基对人MAIT细胞扩增的影响。通过流式细胞术,我们发现Phx显著提高了MAIT细胞的增殖能力,并导致CD4+ MAIT细胞的频率降低,这与Th1效应和细胞溶解功能的降低有关。我们发现,在Phx培养基中培养MAIT细胞比在fbs培养基中培养的MAIT细胞存活率更高,PD-1+ MAIT细胞的频率更低。在功能上,我们发现在大肠杆菌刺激后,与补充fbs的RPMI相比,补充Phx与更高频率的IFN-γ+ MAIT细胞相关。综上所述,我们发现在Phx中培养的MAIT细胞在大肠杆菌刺激后具有更高的增殖能力,抑制受体的表达较低,并且产生IFN-γ的能力高于fbs补充的RPMI。这项工作表明,与fbs补充的RPMI相比,用Phx扩增MAIT细胞可以获得功能更理想的MAIT细胞,用于未来的抗肿瘤免疫治疗。
{"title":"Enhancing Mucosal-Associated Invariant T Cell Function and Expansion with Human Selective Serum.","authors":"Daniel Labuz,&nbsp;Jackson Cacioppo,&nbsp;Kelin Li,&nbsp;Jeffrey Aubé,&nbsp;Daniel T Leung","doi":"10.4049/immunohorizons.2200082","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200082","url":null,"abstract":"<p><p>Mucosal-associated invariant T (MAIT) cells are promising innate-like lymphocytes with potential for use in anti-tumor immunotherapy. Existing MAIT cell expansion protocols are associated with potentially decremental phenotypic changes, including increased frequency of CD4+ MAIT cells and higher inhibitory receptor expression. In this study, we compared the effect on expansion of human MAIT cells of a serum replacement, Physiologix XF SR (Phx), with traditional serum FBS for supplementing RPMI 1640 media. Using flow cytometry, we found that Phx supported a significantly higher proliferative capacity for MAIT cells and resulted in a lower frequency of CD4+ MAIT cells, which have been associated with reduced Th1 effector and cytolytic functions. We saw that culturing MAIT cells in Phx led to better survival of MAIT cells and lower frequency of PD-1+ MAIT cells than FBS-supplemented media. Functionally, we saw that Phx supplementation was associated with a higher frequency of IFN-γ+ MAIT cells after stimulation with Escherichia coli than FBS-supplemented RPMI. In conclusion, we show that MAIT cells cultured in Phx have higher proliferative capacity, lower expression of inhibitory receptors, and higher capacity to produce IFN-γ after E. coli stimulation than FBS-supplemented RPMI. This work shows that expanding MAIT cells with Phx compared with FBS-supplemented RPMI results in a more functionally desirable MAIT cell for future anti-tumor immunotherapy.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/7e/nihms-1877429.PMC10026854.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10478979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology. TET蛋白在聚光灯下:新概念的表观遗传调控在T细胞生物学。
Pub Date : 2023-01-01 DOI: 10.4049/immunohorizons.2200067
Ageliki Tsagaratou

Ten-eleven translocation (TET) proteins are dioxygenases that oxidize 5-methylcytosine to form 5-hydroxymethylcytosine and downstream oxidized modified cytosines. In the past decade, intensive research established that TET-mediated DNA demethylation is critical for immune cell development and function. In this study, we discuss major advances regarding the role of TET proteins in regulating gene expression in the context of T cell lineage specification, function, and proliferation. Then, we focus on open questions in the field. We discuss recent findings regarding the diverse roles of TET proteins in other systems, and we ask how these findings might relate to T cell biology. Finally, we ask how this tremendous progress on understanding the multifaceted roles of TET proteins in shaping T cell identity and function can be translated to improve outcomes of human disease, such as hematological malignancies and immune response to cancer.

十-十一易位(TET)蛋白是氧化5-甲基胞嘧啶形成5-羟甲基胞嘧啶和下游氧化修饰胞嘧啶的双加氧酶。在过去的十年里,深入的研究表明,TET介导的DNA去甲基化对免疫细胞的发育和功能至关重要。在这项研究中,我们讨论了TET蛋白在T细胞谱系规范、功能和增殖中调节基因表达的作用的主要进展。然后,我们集中讨论该领域的开放性问题。我们讨论了最近关于TET蛋白在其他系统中的不同作用的发现,并询问这些发现与T细胞生物学有何关系。最后,我们想知道,在理解TET蛋白在塑造T细胞身份和功能方面的多方面作用方面取得的巨大进展如何转化为改善人类疾病的结果,如血液系统恶性肿瘤和对癌症的免疫反应。
{"title":"TET Proteins in the Spotlight: Emerging Concepts of Epigenetic Regulation in T Cell Biology.","authors":"Ageliki Tsagaratou","doi":"10.4049/immunohorizons.2200067","DOIUrl":"10.4049/immunohorizons.2200067","url":null,"abstract":"<p><p>Ten-eleven translocation (TET) proteins are dioxygenases that oxidize 5-methylcytosine to form 5-hydroxymethylcytosine and downstream oxidized modified cytosines. In the past decade, intensive research established that TET-mediated DNA demethylation is critical for immune cell development and function. In this study, we discuss major advances regarding the role of TET proteins in regulating gene expression in the context of T cell lineage specification, function, and proliferation. Then, we focus on open questions in the field. We discuss recent findings regarding the diverse roles of TET proteins in other systems, and we ask how these findings might relate to T cell biology. Finally, we ask how this tremendous progress on understanding the multifaceted roles of TET proteins in shaping T cell identity and function can be translated to improve outcomes of human disease, such as hematological malignancies and immune response to cancer.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152628/pdf/nihms-1866747.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9766290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study. 在术后早期非小细胞肺癌癌症患者中通过不变的NKT配体负载APC增强颗粒酶B-表达NK细胞:随机II期研究结果。
Pub Date : 2023-01-01 DOI: 10.4049/immunohorizons.2200091
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-Ichiro Shimamatsu, Mitsuhiro Takenoyama, Youko Suehiro, Takumi Imai, Ayumi Shintani, Suminobu Ito, Shin-Ichiro Fujii

NK cells are major effector cells involved in the elimination of early tumors and prevent metastasis. They often have an impaired function in patients with cancer. Preclinical studies have demonstrated NK cell activation as the adjunctive effect of invariant NKT (iNKT) cells. Activation of iNKT cells after administration of the glycolipid ligand α-galactosylceramide, loaded with CD1d-expressing human PBMC-derived APCs (APC/Gal), is an attractive cancer therapy to optimize the use of NK cells. However, the subsets of NK cells that are activated following iNKT cell activation as well as the period of NK cell activation remain unclear. In this study, we report that the granzyme B-expressing NK cell response in postoperative lung cancer patients was enhanced 49 d after administration of APC/Gal in a phase II study. We found maximum IFN-γ production on day 49 in 13 out of 27 APC/Gal-treated patients. On day 49, 14 out of 27 patients (51.9%) had higher IFN-γ production by iNKT cells (>6-fold higher than the baseline level). This increment significantly correlated with granzyme B-expressing NK cells. Although IFN-γ production was lower in patients in the nontreated group, we detected maximum IFN-γ production 12 mo after the resection of lung cancer (9 out of 29 patients [31%]). These findings suggest that elimination of cancer cells leads to increased NK cell function, which can be further enhanced by APC/Gal therapy.

NK细胞是参与消除早期肿瘤和预防转移的主要效应细胞。在癌症患者中,它们通常具有受损的功能。临床前研究表明,NK细胞活化是不变NKT(iNKT)细胞的辅助作用。在给予糖脂配体α-半乳糖神经酰胺(负载CD1d表达人PBMC衍生的APC(APC/Gal))后激活iNKT细胞是一种有吸引力的癌症疗法,以优化NK细胞的使用。然而,iNKT细胞激活后被激活的NK细胞亚群以及NK细胞激活的时间尚不清楚。在本研究中,我们报道了在一项II期研究中,癌症术后患者服用APC/Gal 49天后颗粒酶B表达NK细胞反应增强。我们发现,在27名接受APC/Gal治疗的患者中,有13名患者在第49天产生了最大的IFN-γ。在第49天,27名患者中有14名(51.9%)的iNKT细胞产生了更高的IFN-γ(比基线水平高出6倍以上)。这种增加与表达颗粒酶B的NK细胞显著相关。尽管非治疗组患者的IFN-γ产量较低,但我们在癌症切除后12个月检测到IFN-γ的最大产量(29例患者中有9例[31%])。这些发现表明,消除癌症细胞会增加NK细胞功能,而APC/Gal治疗可以进一步增强NK细胞功能。
{"title":"Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study.","authors":"Tomonori Iyoda,&nbsp;Kanako Shimizu,&nbsp;Masami Kawamura,&nbsp;Jun Shinga,&nbsp;Takashi Watanabe,&nbsp;Koya Fukunaga,&nbsp;Taisei Mushiroda,&nbsp;Hideo Saka,&nbsp;Chiyoe Kitagawa,&nbsp;Shin-Ichiro Shimamatsu,&nbsp;Mitsuhiro Takenoyama,&nbsp;Youko Suehiro,&nbsp;Takumi Imai,&nbsp;Ayumi Shintani,&nbsp;Suminobu Ito,&nbsp;Shin-Ichiro Fujii","doi":"10.4049/immunohorizons.2200091","DOIUrl":"10.4049/immunohorizons.2200091","url":null,"abstract":"<p><p>NK cells are major effector cells involved in the elimination of early tumors and prevent metastasis. They often have an impaired function in patients with cancer. Preclinical studies have demonstrated NK cell activation as the adjunctive effect of invariant NKT (iNKT) cells. Activation of iNKT cells after administration of the glycolipid ligand α-galactosylceramide, loaded with CD1d-expressing human PBMC-derived APCs (APC/Gal), is an attractive cancer therapy to optimize the use of NK cells. However, the subsets of NK cells that are activated following iNKT cell activation as well as the period of NK cell activation remain unclear. In this study, we report that the granzyme B-expressing NK cell response in postoperative lung cancer patients was enhanced 49 d after administration of APC/Gal in a phase II study. We found maximum IFN-γ production on day 49 in 13 out of 27 APC/Gal-treated patients. On day 49, 14 out of 27 patients (51.9%) had higher IFN-γ production by iNKT cells (>6-fold higher than the baseline level). This increment significantly correlated with granzyme B-expressing NK cells. Although IFN-γ production was lower in patients in the nontreated group, we detected maximum IFN-γ production 12 mo after the resection of lung cancer (9 out of 29 patients [31%]). These findings suggest that elimination of cancer cells leads to increased NK cell function, which can be further enhanced by APC/Gal therapy.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/27/ih2200091.PMC10563390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9266023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus. 血载微粒是2型糖尿病的炎症刺激物。
Pub Date : 2023-01-01 DOI: 10.4049/immunohorizons.2200099
Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat, Nandita Mitra, Ole Hoffstad, D Scot Malay, Ziad K Mirza, John C Lantis, Hadar A Lev-Tov, Robert S Kirsner, Ru-Ching Hsia, Susan L Levinson, Mark J DiNubile, David J Margolis

The proinflammatory state associated with diabetes mellitus (DM) remains poorly understood. We found patients with DM have 3- to 14-fold elevations of blood-borne microparticles (MPs) that bind phalloidin (Ph; Ph positive [+] MPs), indicating the presence of F-actin on their surface. We hypothesized that F-actin-coated MPs were an unrecognized cause for DM-associated proinflammatory status. Ph+MPs, but not Ph-negative MPs, activate human and murine (Mus musculus) neutrophils through biophysical attributes of F-actin and membrane expression of phosphatidylserine (PS). Neutrophils respond to Ph+MPs via a linked membrane array, including the receptor for advanced glycation end products and CD36, PS-binding membrane receptors. These proteins in conjunction with TLR4 are coupled to NO synthase 1 adaptor protein (NOS1AP). Neutrophil activation occurs because of Ph+MPs causing elevations of NF-κB and Src kinase (SrcK) via a concurrent increased association of NO synthase 2 and SrcK with NOS1AP, resulting in SrcK S-nitrosylation. We conclude that NOS1AP links PS-binding receptors with intracellular regulatory proteins. Ph+MPs are alarmins present in normal human plasma and are increased in those with DM and especially those with DM and a lower-extremity ulcer.

与糖尿病(DM)相关的促炎状态仍知之甚少。我们发现糖尿病患者的血源性微粒(MP)与鬼笔肽结合(Ph;Ph阳性[+]MP)的水平升高了3到14倍,表明其表面存在F-肌动蛋白。我们假设F-光化MP是糖尿病相关促炎状态的一个未被认识的原因。Ph+MP,而不是Ph阴性MP,通过F-肌动蛋白的生物物理特性和磷脂酰丝氨酸(PS)的膜表达激活人类和小鼠(Mus musculus)中性粒细胞。中性粒细胞通过连接的膜阵列对Ph+MP作出反应,包括晚期糖基化终产物受体和CD36、PS结合膜受体。这些蛋白质结合TLR4与NO合酶1衔接蛋白(NOS1AP)偶联。中性粒细胞活化的发生是因为Ph+MP通过同时增加NO合成酶2和SrcK与NOS1AP的结合,导致NF-κB和Src激酶(SrcK)升高,从而导致SrcK S-亚硝基化。我们得出结论,NOS1AP将PS结合受体与细胞内调节蛋白连接起来。Ph+MP是正常人血浆中存在的危言耸听现象,在糖尿病患者中增加,尤其是在糖尿病和下肢溃疡患者中。
{"title":"Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.","authors":"Stephen R Thom,&nbsp;Veena M Bhopale,&nbsp;Awadhesh K Arya,&nbsp;Deepa Ruhela,&nbsp;Abid R Bhat,&nbsp;Nandita Mitra,&nbsp;Ole Hoffstad,&nbsp;D Scot Malay,&nbsp;Ziad K Mirza,&nbsp;John C Lantis,&nbsp;Hadar A Lev-Tov,&nbsp;Robert S Kirsner,&nbsp;Ru-Ching Hsia,&nbsp;Susan L Levinson,&nbsp;Mark J DiNubile,&nbsp;David J Margolis","doi":"10.4049/immunohorizons.2200099","DOIUrl":"10.4049/immunohorizons.2200099","url":null,"abstract":"<p><p>The proinflammatory state associated with diabetes mellitus (DM) remains poorly understood. We found patients with DM have 3- to 14-fold elevations of blood-borne microparticles (MPs) that bind phalloidin (Ph; Ph positive [+] MPs), indicating the presence of F-actin on their surface. We hypothesized that F-actin-coated MPs were an unrecognized cause for DM-associated proinflammatory status. Ph+MPs, but not Ph-negative MPs, activate human and murine (Mus musculus) neutrophils through biophysical attributes of F-actin and membrane expression of phosphatidylserine (PS). Neutrophils respond to Ph+MPs via a linked membrane array, including the receptor for advanced glycation end products and CD36, PS-binding membrane receptors. These proteins in conjunction with TLR4 are coupled to NO synthase 1 adaptor protein (NOS1AP). Neutrophil activation occurs because of Ph+MPs causing elevations of NF-κB and Src kinase (SrcK) via a concurrent increased association of NO synthase 2 and SrcK with NOS1AP, resulting in SrcK S-nitrosylation. We conclude that NOS1AP links PS-binding receptors with intracellular regulatory proteins. Ph+MPs are alarmins present in normal human plasma and are increased in those with DM and especially those with DM and a lower-extremity ulcer.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/e3/ih2200099.PMC10563440.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10703561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
IL-6/STAT3 Signaling Axis Enhances and Prolongs Pdcd1 Expression in Murine CD8 T Cells. IL-6/STAT3 信号轴增强并延长了小鼠 CD8 T 细胞中 Pdcd1 的表达。
Pub Date : 2022-12-01 DOI: 10.4049/immunohorizons.2100112
Michael D Powell, Peiyuan Lu, Dennis K Neeld, Anna K Kania, Lou-Ella M M George-Alexander, Alexander P R Bally, Christopher D Scharer, Jeremy M Boss

CD8 cytotoxic T cells are a potent line of defense against invading pathogens. To aid in curtailing aberrant immune responses, the activation status of CD8 T cells is highly regulated. One mechanism in which CD8 T cell responses are dampened is via signaling through the immune-inhibitory receptor Programmed Cell Death Protein-1, encoded by Pdcd1. Pdcd1 expression is regulated through engagement of the TCR, as well as by signaling from extracellular cytokines. Understanding such pathways has influenced the development of numerous clinical treatments. In this study, we showed that signals from the cytokine IL-6 enhanced Pdcd1 expression when paired with TCR stimulation in murine CD8 T cells. Mechanistically, signals from IL-6 were propagated through activation of the transcription factor STAT3, resulting in IL-6-dependent binding of STAT3 to Pdcd1 cis-regulatory elements. Intriguingly, IL-6 stimulation overcame B Lymphocyte Maturation Protein 1-mediated epigenetic repression of Pdcd1, which resulted in a transcriptionally permissive landscape marked by heightened histone acetylation. Furthermore, in vivo-activated CD8 T cells derived from lymphocytic choriomeningitis virus infection required STAT3 for optimal Programmed Cell Death Protein-1 surface expression. Importantly, STAT3 was the only member of the STAT family present at Pdcd1 regulatory elements in lymphocytic choriomeningitis virus Ag-specific CD8 T cells. Collectively, these data define mechanisms by which the IL-6/STAT3 signaling axis can enhance and prolong Pdcd1 expression in murine CD8 T cells.

CD8 细胞毒性 T 细胞是抵御病原体入侵的一道强有力的防线。为了帮助抑制异常免疫反应,CD8 T 细胞的活化状态受到高度调控。抑制 CD8 T 细胞反应的机制之一是通过 Pdcd1 编码的免疫抑制受体程序性细胞死亡蛋白-1 发出信号。Pdcd1 的表达通过 TCR 的参与以及细胞外细胞因子的信号来调节。对这些途径的了解影响了许多临床治疗方法的开发。在这项研究中,我们发现当细胞因子IL-6的信号与小鼠CD8 T细胞中的TCR刺激配对时,会增强Pdcd1的表达。从机制上讲,IL-6的信号通过激活转录因子STAT3传播,导致STAT3与Pdcd1顺式调控元件的结合依赖于IL-6。耐人寻味的是,IL-6的刺激克服了B淋巴细胞成熟蛋白1介导的Pdcd1表观遗传抑制,从而形成了以组蛋白乙酰化增强为标志的转录允许景观。此外,由淋巴细胞性脉络膜炎病毒感染产生的活化 CD8 T 细胞需要 STAT3 来优化程序性细胞死亡蛋白-1 的表面表达。重要的是,STAT3 是淋巴细胞色素膜炎病毒 Ag 特异性 CD8 T 细胞中 Pdcd1 调控元件上 STAT 家族的唯一成员。总之,这些数据确定了IL-6/STAT3信号轴在小鼠CD8 T细胞中增强和延长Pdcd1表达的机制。
{"title":"IL-6/STAT3 Signaling Axis Enhances and Prolongs Pdcd1 Expression in Murine CD8 T Cells.","authors":"Michael D Powell, Peiyuan Lu, Dennis K Neeld, Anna K Kania, Lou-Ella M M George-Alexander, Alexander P R Bally, Christopher D Scharer, Jeremy M Boss","doi":"10.4049/immunohorizons.2100112","DOIUrl":"10.4049/immunohorizons.2100112","url":null,"abstract":"<p><p>CD8 cytotoxic T cells are a potent line of defense against invading pathogens. To aid in curtailing aberrant immune responses, the activation status of CD8 T cells is highly regulated. One mechanism in which CD8 T cell responses are dampened is via signaling through the immune-inhibitory receptor Programmed Cell Death Protein-1, encoded by Pdcd1. Pdcd1 expression is regulated through engagement of the TCR, as well as by signaling from extracellular cytokines. Understanding such pathways has influenced the development of numerous clinical treatments. In this study, we showed that signals from the cytokine IL-6 enhanced Pdcd1 expression when paired with TCR stimulation in murine CD8 T cells. Mechanistically, signals from IL-6 were propagated through activation of the transcription factor STAT3, resulting in IL-6-dependent binding of STAT3 to Pdcd1 cis-regulatory elements. Intriguingly, IL-6 stimulation overcame B Lymphocyte Maturation Protein 1-mediated epigenetic repression of Pdcd1, which resulted in a transcriptionally permissive landscape marked by heightened histone acetylation. Furthermore, in vivo-activated CD8 T cells derived from lymphocytic choriomeningitis virus infection required STAT3 for optimal Programmed Cell Death Protein-1 surface expression. Importantly, STAT3 was the only member of the STAT family present at Pdcd1 regulatory elements in lymphocytic choriomeningitis virus Ag-specific CD8 T cells. Collectively, these data define mechanisms by which the IL-6/STAT3 signaling axis can enhance and prolong Pdcd1 expression in murine CD8 T cells.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103150/pdf/nihms-1868256.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity. 来自肿瘤组织的单核髓源性抑制细胞是一种命运可塑性有限的分化细胞。
Pub Date : 2022-12-01 DOI: 10.4049/immunohorizons.2200079
Ryan D Calvert, James C Fleet, Pierrick G J Fournier, Patricia Juarez, Grant N Burcham, Jessica M Haverkamp, Theresa A Guise, Timothy L Ratliff, Bennett D Elzey

Owing to ease of access and high yield, most murine myeloid-derived suppressor cell (MDSC) knowledge comes from the study of spleen-derived MDSCs rather than those isolated from the tumor. Although several studies have identified subtle differences in suppressive function between these MDSCs, a recent report demonstrated that the whole peripheral myeloid compartment poorly reflects myeloid populations found at the tumor. We confirm and extend these observations by presenting data that indicate extensive differences exist between peripheral and tumor MDSCs, suggesting that it may be inappropriate to use spleen MDSCs as surrogates for studying tumor MDSCs. Using cytospins, we observed that tumor MDSCs have undergone a morphologic shift from immature myeloid cell forms commonly seen in bone marrow (BM) and spleen MDSCs and acquired mature myeloid cell characteristics. Spleen and BM monocyte-like MDSCs (M-MDSCs) readily responded to differentiation signals for multiple myeloid cell types whereas tumor M-MDSCs had remarkably reduced cellular plasticity. At the time of isolation, M-MDSCs from BM or spleen have little to no T cell suppressive activity whereas those from the tumor possess immediate and efficient T cell suppressive function. Finally, microarray analysis revealed that the transcriptomes of tumor and spleen M-MDSCs possessed >4500 differentially expressed transcripts. We conclude that tumor M-MDSCs are more differentiated and mature, and that they are morphologically, genetically, and functionally distinct from spleen and BM M-MDSCs. These observations have important implications for the design of anti-MDSC therapies and suggest that preclinical studies using nontumor MDSCs could lead to results not applicable to tumor MDSCs.

由于易于获取和高产量,大多数小鼠髓源性抑制细胞(MDSC)的知识来自脾源性MDSC的研究,而不是从肿瘤中分离出来的MDSC。尽管一些研究已经确定了这些MDSCs在抑制功能上的细微差异,但最近的一份报告表明,整个外周髓细胞室不能很好地反映肿瘤中发现的髓细胞群。我们通过提供的数据证实并扩展了这些观察结果,这些数据表明外周MDSCs和肿瘤MDSCs之间存在广泛的差异,这表明使用脾脏MDSCs作为研究肿瘤MDSCs的替代品可能是不合适的。利用细胞自旋,我们观察到肿瘤MDSCs经历了从骨髓(BM)和脾脏MDSCs中常见的未成熟髓样细胞形态到获得成熟髓样细胞特征的形态学转变。脾脏和骨髓单核细胞样MDSCs (M-MDSCs)容易对多髓细胞类型的分化信号做出反应,而肿瘤M-MDSCs的细胞可塑性显著降低。在分离时,来自骨髓或脾脏的M-MDSCs几乎没有T细胞抑制活性,而来自肿瘤的M-MDSCs具有立即有效的T细胞抑制功能。最后,微阵列分析显示,肿瘤和脾脏M-MDSCs的转录组具有>4500个差异表达转录本。我们得出结论,肿瘤M-MDSCs分化和成熟程度更高,并且它们在形态、遗传和功能上与脾脏和骨髓M-MDSCs不同。这些观察结果对抗mdsc疗法的设计具有重要意义,并表明使用非肿瘤MDSCs的临床前研究可能导致不适用于肿瘤MDSCs的结果。
{"title":"Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity.","authors":"Ryan D Calvert,&nbsp;James C Fleet,&nbsp;Pierrick G J Fournier,&nbsp;Patricia Juarez,&nbsp;Grant N Burcham,&nbsp;Jessica M Haverkamp,&nbsp;Theresa A Guise,&nbsp;Timothy L Ratliff,&nbsp;Bennett D Elzey","doi":"10.4049/immunohorizons.2200079","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200079","url":null,"abstract":"<p><p>Owing to ease of access and high yield, most murine myeloid-derived suppressor cell (MDSC) knowledge comes from the study of spleen-derived MDSCs rather than those isolated from the tumor. Although several studies have identified subtle differences in suppressive function between these MDSCs, a recent report demonstrated that the whole peripheral myeloid compartment poorly reflects myeloid populations found at the tumor. We confirm and extend these observations by presenting data that indicate extensive differences exist between peripheral and tumor MDSCs, suggesting that it may be inappropriate to use spleen MDSCs as surrogates for studying tumor MDSCs. Using cytospins, we observed that tumor MDSCs have undergone a morphologic shift from immature myeloid cell forms commonly seen in bone marrow (BM) and spleen MDSCs and acquired mature myeloid cell characteristics. Spleen and BM monocyte-like MDSCs (M-MDSCs) readily responded to differentiation signals for multiple myeloid cell types whereas tumor M-MDSCs had remarkably reduced cellular plasticity. At the time of isolation, M-MDSCs from BM or spleen have little to no T cell suppressive activity whereas those from the tumor possess immediate and efficient T cell suppressive function. Finally, microarray analysis revealed that the transcriptomes of tumor and spleen M-MDSCs possessed >4500 differentially expressed transcripts. We conclude that tumor M-MDSCs are more differentiated and mature, and that they are morphologically, genetically, and functionally distinct from spleen and BM M-MDSCs. These observations have important implications for the design of anti-MDSC therapies and suggest that preclinical studies using nontumor MDSCs could lead to results not applicable to tumor MDSCs.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10465531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk. Acly缺乏通过乙酰辅酶A和代谢-表观遗传串扰促进骨髓生成。
Pub Date : 2022-12-01 DOI: 10.4049/immunohorizons.2200086
Dalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, Andrew R Patterson, Kelsey Voss, Jackie E Bader, Ayaka Sugiura, Zachary A Bacigalupa, Samuel Schaefer, Xiang Ye, Debolanle O Dahunsi, Matthew Z Madden, Kathryn E Wellen, Michael R Savona, P Brent Ferrell, Jeffrey C Rathmell

Hematopoiesis integrates cytokine signaling, metabolism, and epigenetic modifications to regulate blood cell generation. These processes are linked, as metabolites provide essential substrates for epigenetic marks. In this study, we demonstrate that ATP citrate lyase (Acly), which metabolizes citrate to generate cytosolic acetyl-CoA and is of clinical interest, can regulate chromatin accessibility to limit myeloid differentiation. Acly was tested for a role in murine hematopoiesis by small-molecule inhibition or genetic deletion in lineage-depleted, c-Kit-enriched hematopoietic stem and progenitor cells from Mus musculus. Treatments increased the abundance of cell populations that expressed the myeloid integrin CD11b and other markers of myeloid differentiation. When single-cell RNA sequencing was performed, we found that Acly inhibitor-treated hematopoietic stem and progenitor cells exhibited greater gene expression signatures for macrophages and enrichment of these populations. Similarly, the single-cell assay for transposase-accessible chromatin sequencing showed increased chromatin accessibility at genes associated with myeloid differentiation, including CD11b, CD11c, and IRF8. Mechanistically, Acly deficiency altered chromatin accessibility and expression of multiple C/EBP family transcription factors known to regulate myeloid differentiation and cell metabolism, with increased Cebpe and decreased Cebpa and Cebpb. This effect of Acly deficiency was accompanied by altered mitochondrial metabolism with decreased mitochondrial polarization but increased mitochondrial content and production of reactive oxygen species. The bias to myeloid differentiation appeared due to insufficient generation of acetyl-CoA, as exogenous acetate to support alternate compensatory pathways to produce acetyl-CoA reversed this phenotype. Acly inhibition thus can promote myelopoiesis through deprivation of acetyl-CoA and altered histone acetylome to regulate C/EBP transcription factor family activity for myeloid differentiation.

造血整合了细胞因子信号,代谢和表观遗传修饰来调节血细胞的产生。这些过程是相互联系的,因为代谢物为表观遗传标记提供了必要的底物。在这项研究中,我们证明ATP柠檬酸裂解酶(Acly),代谢柠檬酸生成胞浆乙酰辅酶a,具有临床意义,可以调节染色质可及性以限制髓细胞分化。通过小分子抑制或基因缺失来检测Acly在小鼠造血中的作用,这些抑制或基因缺失来自小家鼠的造血干细胞和祖细胞中富含c- kit。治疗增加了表达髓系整合素CD11b和其他髓系分化标志物的细胞群的丰度。当进行单细胞RNA测序时,我们发现Acly抑制剂处理的造血干细胞和祖细胞对巨噬细胞表现出更大的基因表达特征和这些群体的富集。同样,转座酶可及染色质测序的单细胞试验显示,与髓细胞分化相关的基因(包括CD11b、CD11c和IRF8)的染色质可及性增加。在机制上,Acly缺乏改变了染色质可及性和多种C/EBP家族转录因子的表达,这些转录因子调节髓细胞分化和细胞代谢,Cebpe增加,Cebpa和Cebpb减少。这种影响伴随着线粒体代谢的改变,线粒体极化减少,线粒体含量和活性氧的产生增加。骨髓分化的倾向是由于乙酰辅酶a的产生不足,因为外源性醋酸盐支持替代代偿途径产生乙酰辅酶a逆转了这种表型。因此,Acly抑制可以通过剥夺乙酰辅酶a和改变组蛋白乙酰组来促进髓细胞形成,从而调节C/EBP转录因子家族活性,促进髓细胞分化。
{"title":"Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk.","authors":"Dalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, Andrew R Patterson, Kelsey Voss, Jackie E Bader, Ayaka Sugiura, Zachary A Bacigalupa, Samuel Schaefer, Xiang Ye, Debolanle O Dahunsi, Matthew Z Madden, Kathryn E Wellen, Michael R Savona, P Brent Ferrell, Jeffrey C Rathmell","doi":"10.4049/immunohorizons.2200086","DOIUrl":"10.4049/immunohorizons.2200086","url":null,"abstract":"<p><p>Hematopoiesis integrates cytokine signaling, metabolism, and epigenetic modifications to regulate blood cell generation. These processes are linked, as metabolites provide essential substrates for epigenetic marks. In this study, we demonstrate that ATP citrate lyase (Acly), which metabolizes citrate to generate cytosolic acetyl-CoA and is of clinical interest, can regulate chromatin accessibility to limit myeloid differentiation. Acly was tested for a role in murine hematopoiesis by small-molecule inhibition or genetic deletion in lineage-depleted, c-Kit-enriched hematopoietic stem and progenitor cells from Mus musculus. Treatments increased the abundance of cell populations that expressed the myeloid integrin CD11b and other markers of myeloid differentiation. When single-cell RNA sequencing was performed, we found that Acly inhibitor-treated hematopoietic stem and progenitor cells exhibited greater gene expression signatures for macrophages and enrichment of these populations. Similarly, the single-cell assay for transposase-accessible chromatin sequencing showed increased chromatin accessibility at genes associated with myeloid differentiation, including CD11b, CD11c, and IRF8. Mechanistically, Acly deficiency altered chromatin accessibility and expression of multiple C/EBP family transcription factors known to regulate myeloid differentiation and cell metabolism, with increased Cebpe and decreased Cebpa and Cebpb. This effect of Acly deficiency was accompanied by altered mitochondrial metabolism with decreased mitochondrial polarization but increased mitochondrial content and production of reactive oxygen species. The bias to myeloid differentiation appeared due to insufficient generation of acetyl-CoA, as exogenous acetate to support alternate compensatory pathways to produce acetyl-CoA reversed this phenotype. Acly inhibition thus can promote myelopoiesis through deprivation of acetyl-CoA and altered histone acetylome to regulate C/EBP transcription factor family activity for myeloid differentiation.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9102127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Status of Immunology Education in U.S. Medical Schools. 美国医学院免疫学教育现状
Pub Date : 2022-12-01 DOI: 10.4049/immunohorizons.2200076
Austin B Reynolds, Ritvik Bhattacharjee, Yuan Zhao

Immunology is an integral component of undergraduate medical education because of its critical role in many disease processes. Due to the complexity of the subject, the best practice of immunology education in the undergraduate medical curriculum has not been extensively discussed. This study intended to determine the current status of immunology education in U.S. medical schools with the hope of providing insight into curriculum design pertaining to this subject. Immunology curriculum information was collected from the curriculum Web pages of 199 U.S. medical schools, including multiple campuses. Data pertaining to the setting of immunology education such as subjects that are co-taught with immunology, timing of courses, credit hours, and integration level were recorded in Microsoft Excel for analysis. Of 199 U.S. medical schools studied, 174 posted curriculum information related to immunology online. For course settings, 59 (33.9%) offer immunology with microbiology, 42 (24.1%) offer immunology as part of a foundational sciences course, and 18 (10.3%) offer immunology as a stand-alone course. Ten programs (5.7%) have immunology fully integrated in system-based curriculum. Of 119 medical schools that provide information regarding timing, 94 (71.9%) provide immunology education in year 1 of the curriculum, 16 (9.2%) in year 2, and 9 (5.2%) in both years 1 and 2. Differences exist in allopathic versus osteopathic programs in the immunology curriculum setting. Credit hour data were not complete due to inconsistent availability. Our data suggest that immunology education in U.S. medical schools lacks consensus. Continued discussion on best practices of immunology education across U.S. medical schools is recommended.

免疫学是本科医学教育的一个组成部分,因为它在许多疾病过程中起着关键作用。由于该学科的复杂性,免疫学教育在本科医学课程中的最佳实践尚未得到广泛讨论。本研究旨在确定美国医学院免疫学教育的现状,并希望为这一主题的课程设计提供见解。免疫学课程信息是从199所美国医学院(包括多个校区)的课程网页上收集的。在Microsoft Excel中记录免疫学教育设置的相关数据,如与免疫学共同教授的科目、课程时间、学分、整合水平等,以供分析。在199所被研究的美国医学院中,174所在网上发布了与免疫学相关的课程信息。在课程设置方面,59所(33.9%)学校将免疫学与微生物学结合,42所(24.1%)学校将免疫学作为基础科学课程的一部分,18所(10.3%)学校将免疫学作为独立课程。10个专业(5.7%)将免疫学完全纳入系统课程。在119所提供时间信息的医学院中,94所(71.9%)在第一年的课程中提供免疫学教育,16所(9.2%)在第二年提供免疫学教育,9所(5.2%)在第一年和第二年都提供免疫学教育。免疫学课程设置中的对抗疗法与整骨疗法存在差异。由于可用性不一致,学时数据不完整。我们的数据表明,美国医学院的免疫学教育缺乏共识。建议继续讨论美国医学院免疫学教育的最佳实践。
{"title":"Current Status of Immunology Education in U.S. Medical Schools.","authors":"Austin B Reynolds,&nbsp;Ritvik Bhattacharjee,&nbsp;Yuan Zhao","doi":"10.4049/immunohorizons.2200076","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200076","url":null,"abstract":"<p><p>Immunology is an integral component of undergraduate medical education because of its critical role in many disease processes. Due to the complexity of the subject, the best practice of immunology education in the undergraduate medical curriculum has not been extensively discussed. This study intended to determine the current status of immunology education in U.S. medical schools with the hope of providing insight into curriculum design pertaining to this subject. Immunology curriculum information was collected from the curriculum Web pages of 199 U.S. medical schools, including multiple campuses. Data pertaining to the setting of immunology education such as subjects that are co-taught with immunology, timing of courses, credit hours, and integration level were recorded in Microsoft Excel for analysis. Of 199 U.S. medical schools studied, 174 posted curriculum information related to immunology online. For course settings, 59 (33.9%) offer immunology with microbiology, 42 (24.1%) offer immunology as part of a foundational sciences course, and 18 (10.3%) offer immunology as a stand-alone course. Ten programs (5.7%) have immunology fully integrated in system-based curriculum. Of 119 medical schools that provide information regarding timing, 94 (71.9%) provide immunology education in year 1 of the curriculum, 16 (9.2%) in year 2, and 9 (5.2%) in both years 1 and 2. Differences exist in allopathic versus osteopathic programs in the immunology curriculum setting. Credit hour data were not complete due to inconsistent availability. Our data suggest that immunology education in U.S. medical schools lacks consensus. Continued discussion on best practices of immunology education across U.S. medical schools is recommended.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10825257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Lack of Natural IgM Increases Susceptibility and Impairs Anti-Vi Polysaccharide IgG Responses in a Mouse Model of Typhoid. 缺乏天然IgM增加伤寒小鼠模型的易感性并损害抗多糖IgG反应。
Pub Date : 2022-12-01 DOI: 10.4049/immunohorizons.2200088
Akhil S Alugupalli, Matthew P Cravens, Justin A Walker, Dania Gulandijany, Gregory S Dickinson, Genevieve Lewis, Gudrun F Debes, Dieter M Schifferli, Andreas J Bäumler, Kishore R Alugupalli

Circulating IgM present in the body prior to any apparent Ag exposure is referred to as natural IgM. Natural IgM provides protective immunity against a variety of pathogens. Salmonella enterica serovar Typhi (S. Typhi) is the causative agent of typhoid fever in humans. Because mice are not permissive to S. Typhi infection, we employed a murine model of typhoid using S. enterica serovar Typhimurium expressing the Vi polysaccharide (ViPS) of S. Typhi (S. Typhimurium strain RC60) to evaluate the role of natural IgM in pathogenesis. We found that natural mouse IgM binds to S. Typhi and S. Typhimurium. The severity of S. Typhimurium infection in mice is dependent on presence of the natural resistance-associated macrophage protein 1 (Nramp1) allele; therefore, we infected mice deficient in secreted form of IgM (sIgM) on either a Nramp1-resistant (129S) or -susceptible (C57BL/6J) background. We found that the lack of natural IgM results in a significantly increased susceptibility and an exaggerated liver pathology regardless of the route of infection or the Nramp1 allele. Reconstitution of sIgM-/- mice with normal mouse serum or purified polyclonal IgM restored the resistance to that of sIgM+/+ mice. Furthermore, immunization of sIgM-/- mice with heat-killed S. Typhi induced a significantly reduced anti-ViPS IgG and complement-dependent bactericidal activity against S. Typhi in vitro, compared with that of sIgM+/+ mice. These findings indicate that natural IgM is an important factor in reducing the typhoid severity and inducing an optimal anti-ViPS IgG response to vaccination.

在任何明显的银暴露之前存在于体内的循环IgM被称为天然IgM。天然IgM提供对多种病原体的保护性免疫。伤寒沙门氏菌(S. Typhi)是人类伤寒的病原体。由于小鼠不允许伤寒沙门氏菌感染,我们使用表达伤寒沙门氏菌(伤寒沙门氏菌菌株RC60) Vi多糖(ViPS)的肠炎沙门氏菌血清鼠伤寒模型来评估天然IgM在发病机制中的作用。我们发现天然小鼠IgM与伤寒沙门氏菌和鼠伤寒沙门氏菌结合。鼠伤寒沙门氏菌感染小鼠的严重程度取决于天然耐药相关巨噬细胞蛋白1 (Nramp1)等位基因的存在;因此,我们在nramp1耐药(129S)或易感(C57BL/6J)背景下感染缺乏分泌型IgM (sIgM)的小鼠。我们发现,无论感染途径或Nramp1等位基因如何,缺乏天然IgM都会导致易感性显著增加和肝脏病理夸大。用正常小鼠血清或纯化的多克隆IgM重建sIgM-/-小鼠,恢复sIgM+/+小鼠的耐药性。此外,与sIgM+/+小鼠相比,sIgM-/-小鼠热杀伤寒沙门氏菌免疫诱导体外抗vips IgG和补体依赖性杀菌活性显著降低。这些研究结果表明,天然IgM是降低伤寒严重程度和诱导疫苗接种最佳抗vips IgG反应的重要因素。
{"title":"The Lack of Natural IgM Increases Susceptibility and Impairs Anti-Vi Polysaccharide IgG Responses in a Mouse Model of Typhoid.","authors":"Akhil S Alugupalli,&nbsp;Matthew P Cravens,&nbsp;Justin A Walker,&nbsp;Dania Gulandijany,&nbsp;Gregory S Dickinson,&nbsp;Genevieve Lewis,&nbsp;Gudrun F Debes,&nbsp;Dieter M Schifferli,&nbsp;Andreas J Bäumler,&nbsp;Kishore R Alugupalli","doi":"10.4049/immunohorizons.2200088","DOIUrl":"https://doi.org/10.4049/immunohorizons.2200088","url":null,"abstract":"<p><p>Circulating IgM present in the body prior to any apparent Ag exposure is referred to as natural IgM. Natural IgM provides protective immunity against a variety of pathogens. Salmonella enterica serovar Typhi (S. Typhi) is the causative agent of typhoid fever in humans. Because mice are not permissive to S. Typhi infection, we employed a murine model of typhoid using S. enterica serovar Typhimurium expressing the Vi polysaccharide (ViPS) of S. Typhi (S. Typhimurium strain RC60) to evaluate the role of natural IgM in pathogenesis. We found that natural mouse IgM binds to S. Typhi and S. Typhimurium. The severity of S. Typhimurium infection in mice is dependent on presence of the natural resistance-associated macrophage protein 1 (Nramp1) allele; therefore, we infected mice deficient in secreted form of IgM (sIgM) on either a Nramp1-resistant (129S) or -susceptible (C57BL/6J) background. We found that the lack of natural IgM results in a significantly increased susceptibility and an exaggerated liver pathology regardless of the route of infection or the Nramp1 allele. Reconstitution of sIgM-/- mice with normal mouse serum or purified polyclonal IgM restored the resistance to that of sIgM+/+ mice. Furthermore, immunization of sIgM-/- mice with heat-killed S. Typhi induced a significantly reduced anti-ViPS IgG and complement-dependent bactericidal activity against S. Typhi in vitro, compared with that of sIgM+/+ mice. These findings indicate that natural IgM is an important factor in reducing the typhoid severity and inducing an optimal anti-ViPS IgG response to vaccination.</p>","PeriodicalId":13448,"journal":{"name":"ImmunoHorizons","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ImmunoHorizons
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1